The LSAB was created by the legislature in 2007 to assist in maintaining Maryland’s preeminence in the life sciences industry. Comprised of 18 members, the Board includes the Secretary of the Maryland Department of Commerce, a representative designated by the Maryland Technology Development Corporation (TEDCO) and 16 members appointed by the Governor.
Jay A. Perman, MD, has served as president of the University of Maryland, Baltimore (UMB) — Maryland’s only public health, law, and human services university — since 2010. A pediatric gastroenterologist, Dr. Perman continues to practice medicine through his weekly President’s Clinic, where he teaches team-based health care to students of medicine, nursing, dentistry, pharmacy, social work and law.
Dr. Perman first came to UMB in 1999 as chair of the School of Medicine’s Department of Pediatrics. He left Baltimore in 2004 for the University of Kentucky College of Medicine, where he was dean and vice president for clinical affairs. Dr. Perman received a Doctor of Medicine Degree with Distinction from Northwestern University. He completed a fellowship in pediatric gastroenterology at Harvard Medical School and at the Children’s Hospital Medical Center in Boston.
- R. Michael Gill, Secretary – Maryland Department of Commerce
- George Davis, Chief Executive Officer – TEDCO
- Vice Chair: Douglas Jon Liu, Senior Vice President, Head of Global Operations – Qiagen Sciences Inc.
- Christopher P. Austin, M.D., Director, National Center for Advancing Translational Sciences – U.S. National Institutes of Health
- Richard A. Bendis, President and CEO – BioHealth Innovation Inc.
- Jarrod Borkat, Head, External Collaborations, Biotech Hubs and Government Contracting – MedImmune
- William Hearl, Ph.D. President and CEO – Immunomic Therapeutics Inc.
- Marco A. Chacon, Ph.D., Founder and Chairman – Paragon Bioservices, Inc.
- Theodore J. Olsen, President and CEO – PathSensors, Inc.
- Patrick G. O'Shea, Ph.D., Vice President and Chief Research Officer – University of Maryland
- Wendy Perrow, MBA, CEO – AsclepiX Therapeutics
- Karen L. Proudford, Ph.D., President, William E. Proudford Sickle Cell Fund, Inc.; and Professor of Management and Director, Graves Honor Program - Morgan State University
- Sanjay K. Rai, Ph.D., Chief Academic Officer and Senior Vice President for Academic Affairs – Montgomery College
- David W. Smith, Ph.D., Vice President, Global Business Development, Emerging Technologies – Lonza Walkersville, Inc.
- Col. Andrea Stahl, Ph.D., Director, MRMC CBRN Defense Medical Research Coordinating Office and JPC-Radiation Health Effects – U.S. Army Medical Research & Material Command
- Frank F. Weichold, M.D., Ph.D., Director, Critical Path and Regulatory Science Initiatives, Office of the Commissioner – U.S. Food and Drug Administration
- Christy Wyskiel, Senior Advisor to the President and Head of Johns Hopkins Technology Ventures, Johns Hopkins University
Senior Director, Office of BioHealth and Life Sciences
Maryland Department of Commerce
401 E. Pratt Street, 15th Floor
Baltimore, MD 21202
- October 23, 2017, 9:30 a.m – 12:00 p.m University of Maryland, Baltimore BioPark, 801 West Baltimore Street, Invent and Advance Room, Baltimore, MD 21202
- April 10, 2017, 1:00 - 3:30 p.m. Meeting Agenda. Johns Hopkins FastForward, Suite 110, 1812 Ashland Avenue, Baltimore, MD 21205.
- December 6, 2016, 9:00 - 11:30 a.m. Meeting Minutes |Meeting Agenda. Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Room A101, 9600 Gudelsky Drive, Rockville, MD 20850
- October 31, 2016, 12:45 - 4:15 p.m. Meeting Minutes |Meeting Agenda. Montgomery College - Germantown Campus, Bioscience Education Building Room 151, Germantown, MD 20876.